Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Open filters
Search
Tags
Author
Aditi Singhai
Alison Sathe
Anders Vinther
Anne-Caroline Boillot
Barbara W. Unger
Barry Price
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Khushboo Agrawal
Mark Agostino
Michael de la Torre
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Scott Sherrill
Tashil Sharma
Subscribe to our Newsletter
Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.
Conference Spotlight

FDA: A Pillar of Protection for Patients and Industry

FDA
FDA Oversight
Patient Safety
Enforcement

Limiting Plant Access and Sharing Redacted Documents Results in Import Alert and Warning Letter

FDA
import alert
Inspection
Tianjin Darentang Jingwanhong
Tianjin Darentang Jingwanhong Pharmaceutical

Strategies to Improve Your CAPA Program: Addressing Key Compliance Risks

CAPA
CAPA System

What Is a 510(k) Submission? A Complete 2025 Guide

510k
510k submission

503B Outsourcing Facilities: A Complete 2025 Inspection-Readiness Guide

503A
503B
503B outsourcing

Redica Systems Successfully Completes SOC 2® Audit

No items found.

Biologics Inspection Case Studies Highlight API and Drug Product Deficiencies

API
Case Study
CDER
FDA

Understanding MHRA UK Compliance in Pharma and MedTech

No items found.

FDA Inspection Database: An Essential Tool to Prepare for FDA Inspections

FDA
FDA Database
Enforcement

Granules India FDA 483 Includes Potential Contamination and Data Integrity Findings

483
483 Findings
Data Integrity
Form 483
Granules India
Trends

MedTech 2024 Highlights: A Look at iCGM Systems and CPAP Machines

2024 highlights
CPAP Machines
FDA
iCGM
iCGM Systems
Trends

Using CGMP Site Risk Scores to Predict Drug Shortages

CGMP
Drug Shortages
FDA
Predict Drug Shortages
Redica Systems

Addressing FDA’s Biggest Challenges

China
Drug Shortages
FDA
FOIA
import alert

Tianish Laboratories Private Limited: A Timeline of Regulatory Assessments

No items found.
Conference Spotlight

Facility Issues Top Inspection Deficiencies for Biologics

BLAs
CDER
OPMA
OPQ
PDA/FDA
Trends

How Much Can Poor Quality Cost You?

483
483 observation
483 response
Cost of Quality
Quality
Enforcement

Navigating FDA Guidelines for Combination Products: A Comprehensive Guide

Combination Products
FDA Database
FDA Approval
Guidelines
medical devices

KVK-Tech Warning Letters: A Timeline of Regulatory Assessments

No items found.